On ECHEMI
Home > Drugs > Breviscapine for injection

Breviscapine for injection

Ingredients

Breviscapine.

Name Description Content CAS NO. Manufacturer
BREVISCAPINIngredients

Extract from the above information

More
116122-36-2 0

Appearance

This product is a yellow loose mass.

Usage and Dosage

5-10 mg for intramuscular injection, twice a day. Dissolve in 2 ml of water for injection before use. 10-20 mg for intravenous injection, once a day. Dissolve in 250 ml of normal saline or 500 ml of 5% or 10% glucose injection before use.

Adverse Reactions

When using this product, you may occasionally experience itching all over your body, chest tightness, fatigue, rash, palpitations, etc. If the above symptoms occur, please stop taking the drug immediately and treat the symptoms, and the symptoms will disappear.

Precautions

It is contraindicated in patients with hemorrhagic diseases and during the bleeding period of cerebral hemorrhage.

Drug Interactions

1. This product reacts with aminoglycoside drugs (such as gentamicin sulfate) to produce precipitation. The syringes and needles used to dilute this product should avoid contact with aminoglycoside drugs. 2. When this product is used with a solution with a low pH value, the effective ingredients may precipitate. Therefore, it should not be used with infusions or drugs with a pH value lower than 4.2.

Storage

Light-proof and sealed.

Packaging Specification

50mg

Validity Period

36 months

Manufacturer

Kunming Longjin Pharmaceutical Co., Ltd.

  • Founded in:

    1996-09-16
  • Address:

    No. 789, Lanmao Road, Majinpu Subdistrict Office, Kunming High-tech Zone, Kunming City, Yunnan Province
  • Tax NO.:

    9153010062260401XJ
  • Registered Funds:

    400.5 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.